52 related articles for article (PubMed ID: 11895902)
21. Requirement for cyclin D3 in germinal center formation and function.
Peled JU; Yu JJ; Venkatesh J; Bi E; Ding BB; Krupski-Downs M; Shaknovich R; Sicinski P; Diamond B; Scharff MD; Ye BH
Cell Res; 2010 Jun; 20(6):631-46. PubMed ID: 20404856
[TBL] [Abstract][Full Text] [Related]
22. A cytomorphological and immunohistochemical profile of aggressive B-cell lymphoma: high clinical impact of a cumulative immunohistochemical outcome predictor score.
Höller S; Horn H; Lohr A; Mäder U; Katzenberger T; Kalla J; Bernd HW; Went P; Ott MM; Müller-Hermelink HK; Rosenwald A; Ott G
J Hematop; 2009 Sep; 2(4):187-94. PubMed ID: 20309427
[TBL] [Abstract][Full Text] [Related]
23. D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance.
Levidou G; Saetta AA; Karlou M; Thymara I; Pratsinis H; Pavlopoulos P; Isaiadis D; Diamantopoulou K; Patsouris E; Korkolopoulou P
J Cancer Res Clin Oncol; 2010 Oct; 136(10):1563-71. PubMed ID: 20174823
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Significance of in situ Phenotypic Marker Expression in Diffuse Large B-cell Lymphomas.
Tzankov A; Went P; Dirnhofer S
Biomark Insights; 2007 Nov; 2():403-17. PubMed ID: 19662221
[TBL] [Abstract][Full Text] [Related]
25. Effects of betulinic acid on proliferation and apoptosis in Jurkat cells and its in vitro mechanism.
Chen Z; Wu Q; Chen Y; He J
J Huazhong Univ Sci Technolog Med Sci; 2008 Dec; 28(6):634-8. PubMed ID: 19107355
[TBL] [Abstract][Full Text] [Related]
26. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
Joshi I; Minter LM; Telfer J; Demarest RM; Capobianco AJ; Aster JC; Sicinski P; Fauq A; Golde TE; Osborne BA
Blood; 2009 Feb; 113(8):1689-98. PubMed ID: 19001083
[TBL] [Abstract][Full Text] [Related]
27. Clinico-prognostic value of D-type cyclins and p27 in laryngeal cancer patients: a review.
Pignataro L; Sambataro G; Pagani D; Pruneri G
Acta Otorhinolaryngol Ital; 2005 Apr; 25(2):75-85. PubMed ID: 16116829
[TBL] [Abstract][Full Text] [Related]
28. Identification of cyclin D3 as a direct target of E2A using DamID.
Song S; Cooperman J; Letting DL; Blobel GA; Choi JK
Mol Cell Biol; 2004 Oct; 24(19):8790-802. PubMed ID: 15367695
[TBL] [Abstract][Full Text] [Related]
29. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
30. Molecular control of the cell cycle in cancer: biological and clinical aspects.
Møller MB
Dan Med Bull; 2003 May; 50(2):118-38. PubMed ID: 12812137
[TBL] [Abstract][Full Text] [Related]
31. Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.
Filipits M; Jaeger U; Pohl G; Stranzl T; Simonitsch I; Kaider A; Skrabs C; Pirker R
Clin Cancer Res; 2002 Mar; 8(3):729-33. PubMed ID: 11895902
[TBL] [Abstract][Full Text] [Related]
32. Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features.
Møller MB; Nielsen O; Pedersen NT
Am J Clin Pathol; 2001 Mar; 115(3):404-12. PubMed ID: 11242797
[TBL] [Abstract][Full Text] [Related]
33. Cyclin B1 expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
Obermann EC; Went P; Pehrs AC; Tzankov A; Wild PJ; Pileri S; Hofstaedter F; Dirnhofer S
Oncol Rep; 2005 Dec; 14(6):1461-7. PubMed ID: 16273239
[TBL] [Abstract][Full Text] [Related]
34. Reduced or absent cyclin H expression is an independent prognostic marker for poor outcome in diffuse large B-cell lymphoma.
Bavi P; Abubaker J; Hussain A; Sultana M; Al-Dayel F; Uddin S; Al-Kuraya KS
Hum Pathol; 2008 Jun; 39(6):885-94. PubMed ID: 18400256
[TBL] [Abstract][Full Text] [Related]
35. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
36. Diffuse large B-cell lymphoma: clinical and biological characterization and outcome according to the nodal or extranodal primary origin.
López-Guillermo A; Colomo L; Jiménez M; Bosch F; Villamor N; Arenillas L; Muntañola A; Montoto S; Giné E; Colomer D; Beà S; Campo E; Montserrat E
J Clin Oncol; 2005 Apr; 23(12):2797-804. PubMed ID: 15728226
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
